Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric Paul Wehrenberg-Klee, M.D.

Concepts (140)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Yttrium Radioisotopes620211162.320 Why?
Cryosurgery520244791.750 Why?
Carcinoma, Hepatocellular8202123291.410 Why?
Liver Neoplasms11202343531.140 Why?
Immunotherapy10202447521.030 Why?
Embolization, Therapeutic7202314030.780 Why?
Chemoembolization, Therapeutic120211290.700 Why?
Cancer Vaccines1202210440.470 Why?
Radiography, Interventional2201911290.460 Why?
Positron-Emission Tomography8202165470.440 Why?
Granzymes320202780.410 Why?
Microspheres420237730.400 Why?
Combined Modality Therapy6202485290.380 Why?
Neoplasms72024223400.360 Why?
Neoplasms, Experimental1201612290.360 Why?
Molecular Imaging120168220.320 Why?
Receptor, erbB-3220211410.310 Why?
Receptor Protein-Tyrosine Kinases1201616240.310 Why?
Patient Selection2201942550.290 Why?
Catheter Ablation3202127880.260 Why?
Disease Models, Animal22024182930.250 Why?
Glycolates12023410.220 Why?
Splenic Artery12024550.220 Why?
Injections, Intralesional120242810.210 Why?
Stochastic Processes120233580.200 Why?
Ablation Techniques220242540.190 Why?
Radiometry220238040.180 Why?
Aneurysm120243370.180 Why?
Portal Pressure12020620.180 Why?
Adjuvants, Immunologic220239950.180 Why?
Radiation Pneumonitis12020980.170 Why?
Radiopharmaceuticals2202026990.170 Why?
Technology120222970.170 Why?
Tissue Distribution2202122660.170 Why?
Kidney Failure, Chronic1201124950.160 Why?
Genes, cdc120181130.150 Why?
Kidney Neoplasms2201342740.150 Why?
Antineoplastic Agents12021136480.150 Why?
Hypertension, Portal120202290.150 Why?
Liver Transplantation2202124120.150 Why?
Cell Line, Tumor62021170750.140 Why?
Liver Function Tests120195250.140 Why?
Safety1202111570.140 Why?
Carcinoma, Renal Cell1201131810.130 Why?
Immunologic Factors2202215870.130 Why?
Angiography1202015810.120 Why?
Radiotherapy Planning, Computer-Assisted1202316430.120 Why?
Quinazolines1202113640.120 Why?
Hepatectomy120185890.110 Why?
Treatment Outcome112024651880.110 Why?
Salvage Therapy1202112720.110 Why?
Breast Neoplasms12021210560.110 Why?
Tumor Microenvironment2202439460.110 Why?
Brachytherapy1202112220.110 Why?
Mice92024818190.100 Why?
Octreotide120131570.100 Why?
Receptors, Somatostatin120131380.100 Why?
Humans2820247659680.100 Why?
Radiotherapy Dosage1201928650.100 Why?
Lung22020100330.090 Why?
Intestinal Neoplasms120133130.090 Why?
Receptor, erbB-21202125930.090 Why?
Colonic Neoplasms2201825310.080 Why?
Lymphoma1201818970.080 Why?
Animals920241687640.070 Why?
Female1420243961120.070 Why?
Male1320243636980.070 Why?
Tomography, X-Ray Computed32018206590.070 Why?
Neuroendocrine Tumors120136540.070 Why?
Lymph Nodes1201834540.070 Why?
Disease Progression12024136320.070 Why?
Retrospective Studies102024815140.070 Why?
Mice, Inbred C57BL12024223320.060 Why?
Peptides1201843310.060 Why?
Drug Resistance, Neoplasm1202153370.060 Why?
Aged, 80 and over72024594890.060 Why?
Gallium Radioisotopes220181950.060 Why?
Antineoplastic Agents, Hormonal1201315340.060 Why?
Surgery, Computer-Assisted120139930.060 Why?
Hypnotics and Sedatives1201311910.060 Why?
Tumor Burden2202418850.060 Why?
Glomerular Filtration Rate1201122330.050 Why?
Pain, Postoperative1201317720.050 Why?
Cell Proliferation22016104290.050 Why?
Aged920241711170.050 Why?
Colorectal Neoplasms1202169420.050 Why?
Technetium Tc 99m Aggregated Albumin12020680.050 Why?
Middle Aged1020242230090.040 Why?
Sensitivity and Specificity12016146520.040 Why?
Predictive Value of Tests32024153980.040 Why?
Liver Circulation120201630.040 Why?
Time Factors42024400650.040 Why?
Microwaves120211820.040 Why?
Neoplasm, Residual1202410090.040 Why?
Antibodies, Monoclonal1201692490.040 Why?
Retreatment120205980.040 Why?
Somatostatin120204590.040 Why?
Melanoma1201757190.040 Why?
Adult720242230440.040 Why?
Prognosis22016299220.040 Why?
Pulmonary Circulation120207410.040 Why?
Retroperitoneal Space120181730.040 Why?
Reproducibility of Results12016201240.040 Why?
Biotin120182570.030 Why?
Prospective Studies12021548020.030 Why?
Risk Assessment32024242820.030 Why?
Biomarkers, Pharmacological120171620.030 Why?
Risk Factors42024748400.030 Why?
Pelvis120187380.030 Why?
Chemical Fractionation12013600.030 Why?
Droperidol12013210.030 Why?
Radiation Dosage1202019440.020 Why?
Solubility1201310780.020 Why?
Midazolam120132670.020 Why?
Lymphatic Metastasis1201828870.020 Why?
Contrast Media1202353290.020 Why?
Kaplan-Meier Estimate1202164990.020 Why?
Liver Cirrhosis1202019590.020 Why?
Thrombosis1202429490.020 Why?
Hemodynamics1202041840.020 Why?
T-Lymphocytes, Cytotoxic1201718010.020 Why?
Fentanyl120134570.020 Why?
Radionuclide Imaging1201319780.020 Why?
Cohort Studies22021416490.020 Why?
Feasibility Studies1201953020.020 Why?
Models, Biological1202394430.020 Why?
Mice, Inbred BALB C1201662200.020 Why?
Mice, Nude1201336180.020 Why?
Cell Transformation, Neoplastic1201628440.020 Why?
Tumor Cells, Cultured1201361130.020 Why?
Protein Binding1201892960.020 Why?
Biopsy1201767630.020 Why?
Xenograft Model Antitumor Assays1201336080.020 Why?
Young Adult22024598890.010 Why?
Pain Measurement1201335610.010 Why?
Dose-Response Relationship, Drug12013107290.010 Why?
Follow-Up Studies12021391930.010 Why?
Rats12013237070.010 Why?
Child12018805640.010 Why?
Adolescent12018888350.010 Why?
Wehrenberg-Klee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (57)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.